Friday, 30 October 2015
Dechra® Pharmaceuticals PLC
(Dechra or the Company)
Company Secretary Change
The Board of Dechra Pharmaceuticals PLC announces that with effect from 2 November 2015 Suzana Cross will join the Company and take up the role of Company Secretary and General Counsel.
Suzana has a background in corporate and commercial law and holds degrees in business and law together with an MBA. Her career spans over 20 years where she has served within the legal profession in the UK and overseas and within a number of sectors of UK industry.
Prior to joining Dechra Suzana was General Counsel and Company Secretary for Victrex plc.
Enquiries
Ian Page, Chief Executive Officer
Dechra Pharmaceuticals PLC
Tel: +44 (0) 1606 814 730
Email: corporate.enquiries@dechra.com
Fiona Tooley
TooleyStreet Communications Ltd
Tel: +44 (0) 7795 703523
Email: fiona@tooleystreet.com
About Dechra
Stock Code: Full Listing (Pharmaceuticals): DPH
Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.
For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.